Human Genome Epidemiology Literature Finder
Records 1 - 16 (of 16 Records) |
Query Trace: Myelofibrosis and IDH2[original query] |
---|
IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis. Leukemia 2010 Jul 24 (7): 1302-9. Tefferi A, Lasho T L, Abdel-Wahab O, Guglielmelli P, Patel J, Caramazza D, Pieri L, Finke C M, Kilpivaara O, Wadleigh M, Mai M, McClure R F, Gilliland D G, Levine R L, Pardanani A, Vannucchi A |
IDH1 and IDH2 mutation analysis in chronic- and blast-phase myeloproliferative neoplasms. Leukemia 2010 Jun 24 (6): 1146-51. Pardanani A, Lasho T L, Finke C M, Mai M, McClure R F, Tefferi |
IDH mutations in primary myelofibrosis predict leukemic transformation and shortened survival: clinical evidence for leukemogenic collaboration with JAK2V617F. Leukemia 2012 Mar 26 (3): 475-80. Tefferi A, Jimma T, Sulai N H, Lasho T L, Finke C M, Knudson R A, McClure R F, Pardanani |
TET2, ASXL1, IDH1, IDH2, and c-CBL genes in JAK2- and MPL-negative myeloproliferative neoplasms. Annals of hematology 2012 Apr 91 (4): 533-41. Martínez-Avilés Luz, Besses Carlos, Álvarez-Larrán Alberto, Torres Erica, Serrano Sergi, Bellosillo Beatr |
Mutation analysis of ASXL1, CBL, DNMT3A, IDH1, IDH2, JAK2, MPL, NF1, SF3B1, SUZ12, and TET2 in myeloproliferative neoplasms. Genes, chromosomes & cancer 2012 Aug 51 (8): 743-55. Brecqueville Mandy, Rey Jérôme, Bertucci François, Coppin Emilie, Finetti Pascal, Carbuccia Nadine, Cervera Nathalie, Gelsi-Boyer Véronique, Arnoulet Christine, Gisserot Olivier, Verrot Denis, Slama Borhane, Vey Norbert, Mozziconacci Marie-Joelle, Birnbaum Daniel, Murati An |
Mutations and prognosis in primary myelofibrosis. Leukemia 2013 Sep 27 (9): 1861-9. Vannucchi A M, Lasho T L, Guglielmelli P, Biamonte F, Pardanani A, Pereira A, Finke C, Score J, Gangat N, Mannarelli C, Ketterling R P, Rotunno G, Knudson R A, Susini M C, Laborde R R, Spolverini A, Pancrazzi A, Pieri L, Manfredini R, Tagliafico E, Zini R, Jones A, Zoi K, Reiter A, Duncombe A, Pietra D, Rumi E, Cervantes F, Barosi G, Cazzola M, Cross N C P, Tefferi |
CALR mutation screening in pediatric primary myelofibrosis. Pediatric blood & cancer 2014 Dec 61 (12): 2256-62. An Wenbin, Wan Yang, Guo Ye, Chen Xiaojuan, Ren Yuanyuan, Zhang Jingliao, Chang Lixian, Wei Wei, Zhang Peihong, Zhu Xiaof |
A compendium of cytogenetic abnormalities in myelofibrosis: molecular and phenotypic correlates in 826 patients. British journal of haematology 2015 Apr 169 (1): 71-6. Wassie Emnet, Finke Christy, Gangat Naseema, Lasho Terra L, Pardanani Animesh, Hanson Curtis A, Ketterling Rhett P, Tefferi Ayal |
The Clinical Significance of IDH Mutations in Essential Thrombocythemia and Primary Myelofibrosis. Journal of clinical medicine research 2016 Jan 8 (1): 29-39. Yonal-Hindilerden Ipek, Daglar-Aday Aynur, Hindilerden Fehmi, Akadam-Teker Basak, Yilmaz Ceylan, Nalcaci Meliha, Yavuz Akif Selim, Sargin Den |
Epidemiology and clinical relevance of mutations in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 359 patients of the AGIMM group. American journal of hematology 2016 Apr . Rotunno Giada, Pacilli Annalisa, Artusi Valentina, Rumi Elisa, Maffioli Margherita, Delaini Federica, Brogi Giada, Fanelli Tiziana, Pancrazzi Alessandro, Pietra Daniela, Bernardis Isabella, Belotti Clara, Pieri Lisa, Sant'Antonio Emanuela, Salmoiraghi Silvia, Cilloni Daniela, Rambaldi Alessandro, Passamonti Francesco, Barbui Tiziano, Manfredini Rossella, Cazzola Mario, Tagliafico Enrico, Vannucchi Alessandro M, Guglielmelli Pao |
Application of an NGS-based 28-gene panel in myeloproliferative neoplasms reveals distinct mutation patterns in essential thrombocythaemia, primary myelofibrosis and polycythaemia vera. British journal of haematology 2016 Nov 175 (3): 419-426. Delic Sabit, Rose Dominic, Kern Wolfgang, Nadarajah Niroshan, Haferlach Claudia, Haferlach Torsten, Meggendorfer Man |
TET2, ASXL1, IDH1, and IDH2 Single Nucleotide Polymorphisms in Turkish Patients with Chronic Myeloproliferative Neoplasms. Turkish journal of haematology : official journal of Turkish Society of Haematology 2017 Feb . Soyer Nur, Tezcanl? Kaymaz Burçin, Cömert Özkan Melda, Aktan Ça?da?, Küçükaslan Ali ?ahin, ?ahin Fahri, Kosova Buket, Saydam Gür |
Allogeneic stem cell transplantation in patients with myelofibrosis harboring the MPL mutation. European journal of haematology 2019 Aug . Mannina Daniele, Gagelmann Nico, Badbaran Anita, Ditschkowski Markus, Bogdanov Rashit, Robin Marie, Cassinat Bruno, Heuser Michael, Shahswar Rabia, Thol Felicitas, Beelen Dietrich, Kröger Nicola |
Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study. Blood advances 2021 Mar 5 (5): 1442-1451. Luque Paz Damien, Riou Jérémie, Verger Emmanuelle, Cassinat Bruno, Chauveau Aurélie, Ianotto Jean-Christophe, Dupriez Brigitte, Boyer Françoise, Renard Maxime, Mansier Olivier, Murati Anne, Rey Jérôme, Etienne Gabriel, Mansat-De Mas Véronique, Tavitian Suzanne, Nibourel Olivier, Girault Stéphane, Le Bris Yannick, Girodon François, Ranta Dana, Chomel Jean-Claude, Cony-Makhoul Pascale, Sujobert Pierre, Robles Margot, Ben Abdelali Raouf, Kosmider Olivier, Cottin Laurane, Roy Lydia, Sloma Ivan, Vacheret Fabienne, Wemeau Mathieu, Mossuz Pascal, Slama Borhane, Cussac Vincent, Denis Guillaume, Walter-Petrich Anouk, Burroni Barbara, Jézéquel Nathalie, Giraudier Stéphane, Lippert Eric, Socié Gérard, Kiladjian Jean-Jacques, Ugo Valér |
Lab tests for MPN. International review of cell and molecular biology 2022 2 366 187-220. Moncada Alice, Pancrazzi Alessand |
JAK2V617F variant allele frequency, non-driver mutations, single-nucleotide variants and polycythemia vera outcome. Journal of cancer research and clinical oncology 2022 Oct . Kandu?a Zuzanna, Janowski Micha?, Wi?ckowska Barbara, Paczkowska Edyta, Lewandowski Krzyszt |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: